A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 18, Issue 4, Pages 521-528
Publisher
Springer Nature
Online
2012-03-19
DOI
10.1038/nm.2713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes
- (2011) A. M. Hillmer et al. GENOME RESEARCH
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
- (2011) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- Acute Mesenteric Infarction Associated with Atrial Fibrillation
- (2011) Jia-Ming Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- BIM Expression in Treatment-Naive Cancers Predicts Responsiveness to Kinase Inhibitors
- (2011) A. C. Faber et al. Cancer Discovery
- Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells
- (2010) B. Will et al. BLOOD
- Role for the Proapoptotic Factor BIM in Mediating Imatinib-induced Apoptosis in a c-KIT-dependent Gastrointestinal Stromal Tumor Cell Line
- (2010) Peter M. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in EGFR Mutation-Positive Patients with Non-small Cell Lung Cancer
- (2010) Masayuki Takeda et al. Journal of Thoracic Oncology
- Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling
- (2010) Kazuya Machida et al. PLoS One
- Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses
- (2009) M. J. Fullwood et al. GENOME RESEARCH
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
- (2009) Michele Baccarani et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
- (2009) Pasi A. Jänne et al. NATURE REVIEWS DRUG DISCOVERY
- Methodology of the Singapore Indian Chinese Cohort (SICC) Eye Study: Quantifying ethnic variations in the epidemiology of eye diseases in Asians
- (2009) Raghavan Lavanya et al. OPHTHALMIC EPIDEMIOLOGY
- Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
- (2008) Neil P. Shah et al. CANCER CELL
- Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
- (2008) S. Yano et al. CANCER RESEARCH
- Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response
- (2008) J.-Y. Wu et al. CLINICAL CANCER RESEARCH
- Chronic myeloid leukemia in Asia
- (2008) Wing Y. Au et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs
- (2008) Joshua M Korn et al. NATURE GENETICS
- Resistance to imatinib in chronic myelogenous leukemia: Mechanisms and clinical implications
- (2008) Paul La Rosée et al. Current Hematologic Malignancy Reports
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now